Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sui-Xing Zhong

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Clinical and Molecular Hepatology|August 18, 2025
Beyond Diagnostic Accuracy: Economic and Clinical Considerations for NC-MRI in Late HCC Recurrence SurveillanceQi-Feng Chen, Sui-Xing Zhong, Ming Zhao
International Journal of Surgery (London, England)|January 20, 2026
Methodological considerations and optimization directions for bibliometric researchSong-Bin Guo, Sui-Xing Zhong, Xiao-Peng Tian
Clinical and Molecular Hepatology|September 23, 2025
Reply to "Correspondence to Economic and Clinical Considerations for NC-MRI in Late HCC Recurrence Surveillance"Qi-Feng Chen, Sui-Xing Zhong, Xiong-Ying Jiang, et al.
Journal of Hepatocellular Carcinoma|August 6, 2024
Additional Hepatic Arterial Infusion Chemotherapy to Sorafenib Was Cost-Effective for Hepatocellular Carcinoma with Major Portal Vein Tumor ThrombosisQi-Feng Chen, Xiong-Ying Jiang, Yue Hu, et al.
International Journal of Surgery (London, England)|September 7, 2023
Cost-effectiveness and prognostic model of hepatic arterial infusion chemotherapy for hepatocellular carcinoma with high tumor burden and/or Vp4 tumor thrombus compared with sorafenib: a post-hoc analysis of the FOHAIC-1 trialQi-Feng Chen, Ning Lyu, Xun Wang, et al.
The American Journal of Gastroenterology|March 25, 2024
Recommended 10-Year Follow-Up Strategy for Small Hepatocellular Carcinoma After Radiofrequency Ablation: A Cost-Effectiveness EvaluationQi-Feng Chen, Song Chen, Jun-Zhe Yi, et al.
Journal of Gastrointestinal Oncology|March 21, 2025
Efficacy and safety of arterial FOLFOX chemotherapy plus anti-PD-(L)1 immunotherapy as a first-line treatment for unresectable intrahepatic cholangiocarcinoma: a propensity score matching analysisYue Hu, Xiong-Ying Jiang, Xi Cai, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 28, 2023
Hepatic arterial infusion therapy for advanced hepatocellular carcinoma after systemic treatment failure: Multicenter, real-world studyJun-Zhe Yi, Zhi-Jian Zhu, Gong-Wei Liu, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Clinical and Molecular Hepatology|August 18, 2025
Beyond Diagnostic Accuracy: Economic and Clinical Considerations for NC-MRI in Late HCC Recurrence SurveillanceQi-Feng Chen, Sui-Xing Zhong, Ming Zhao
International Journal of Surgery (London, England)|January 20, 2026
Methodological considerations and optimization directions for bibliometric researchSong-Bin Guo, Sui-Xing Zhong, Xiao-Peng Tian
Clinical and Molecular Hepatology|September 23, 2025
Reply to "Correspondence to Economic and Clinical Considerations for NC-MRI in Late HCC Recurrence Surveillance"Qi-Feng Chen, Sui-Xing Zhong, Xiong-Ying Jiang, et al.
Journal of Hepatocellular Carcinoma|August 6, 2024
Additional Hepatic Arterial Infusion Chemotherapy to Sorafenib Was Cost-Effective for Hepatocellular Carcinoma with Major Portal Vein Tumor ThrombosisQi-Feng Chen, Xiong-Ying Jiang, Yue Hu, et al.
International Journal of Surgery (London, England)|September 7, 2023
Cost-effectiveness and prognostic model of hepatic arterial infusion chemotherapy for hepatocellular carcinoma with high tumor burden and/or Vp4 tumor thrombus compared with sorafenib: a post-hoc analysis of the FOHAIC-1 trialQi-Feng Chen, Ning Lyu, Xun Wang, et al.
The American Journal of Gastroenterology|March 25, 2024
Recommended 10-Year Follow-Up Strategy for Small Hepatocellular Carcinoma After Radiofrequency Ablation: A Cost-Effectiveness EvaluationQi-Feng Chen, Song Chen, Jun-Zhe Yi, et al.
Journal of Gastrointestinal Oncology|March 21, 2025
Efficacy and safety of arterial FOLFOX chemotherapy plus anti-PD-(L)1 immunotherapy as a first-line treatment for unresectable intrahepatic cholangiocarcinoma: a propensity score matching analysisYue Hu, Xiong-Ying Jiang, Xi Cai, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 28, 2023
Hepatic arterial infusion therapy for advanced hepatocellular carcinoma after systemic treatment failure: Multicenter, real-world studyJun-Zhe Yi, Zhi-Jian Zhu, Gong-Wei Liu, et al.
Pageof 1